Galderma articles

Galderma is certainly the heavyweight for rosacea treatments and skincare. Rosacea sufferers will be familiar with Metrogel 1% and Oracea as well as their Cetaphil skincare range. More recently Galderma has gained approval for Mirvaso and also has CD5024/Ivermectin in development.

 

Recent Posts

Soolantra Savings Card Now Available

Coinciding with the launch of the official web site for Soolantra, Galderma has made available a savings card for Soolantra. The card will allow a potential reduction in any out-of-pocket expenses for a Soolantra prescription, for insured patients. This savings card is similar in operation to Galderma’s cost reduction card for Mirvaso. The terms and […]

Continue Reading

East Indian Sandalwood Oil in Benzac Acne Solutions

A local angle for an Australian commercial producer of East Indian Sandalwood Oil. West Australian based TFS is touting its supply of East Indian Sandalwood Oil to Galderma for use in the just released over the counter Benzac Acne Solutions product. TFS is said to be the world’s only supplier of pharmaceutical-grade sandalwood oil, and […]

Continue Reading

Galderma announces approval of Soolantra

Galderma has announced today that their 1% Ivermectin cream in development for rosacea as CD5024 has been approved and is now known as Soolantra. Soolantra appears to be going to be promoted as a treatment that is quicker and more effective than Metrogel 0.75%. Soolantra has been in development as CD5024 for many years. The […]

Continue Reading

OK, I’m going to scoop everyone and say that Galderma is going to launch their 1% Ivermectin Cream as Soolantra. I haven’t seen anything official but today I saw 2 new big hints that Soolantra will be the new product name. Here’s what I know; Galderma has registered Soolantra as a trademark and likes to use […]

Continue Reading

Say goodbye to Generic Oracea

A recent ruling from the U.S. Patent and Trademark Office has put the final nail in coffin of the hopes for the availability of Generic Oracea. Rosacea sufferers will need to wait until that late 2020’s until the current patents protecting Oracea expire. Concerted efforts from Amneal Pharmaceuticals and Mylan Inc. have both failed to […]

Continue Reading

Top